Cross Country Healthcare (CCRN) Set to Announce Earnings on Wednesday

Cross Country Healthcare (NASDAQ:CCRN) is scheduled to be announcing its earnings results after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.17 per share for the quarter. Cross Country Healthcare has set its Q1 guidance at $0.15-0.25 EPS and its Q1 2024 guidance at 0.150-0.250 EPS.Individual that wish to listen to the company’s earnings conference call can do so using this link.

Cross Country Healthcare (NASDAQ:CCRN) last posted its quarterly earnings data on Wednesday, February 21st. The business services provider reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.02. The business had revenue of $414.04 million during the quarter, compared to analysts’ expectations of $404.42 million. Cross Country Healthcare had a return on equity of 16.93% and a net margin of 3.60%. The firm’s revenue was down 34.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.09 EPS. On average, analysts expect Cross Country Healthcare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Cross Country Healthcare Stock Up 4.4 %

CCRN opened at $17.77 on Wednesday. Cross Country Healthcare has a 12-month low of $15.65 and a 12-month high of $28.75. The firm has a market capitalization of $616.21 million, a P/E ratio of 8.75, a price-to-earnings-growth ratio of 1.85 and a beta of 0.75. The stock’s 50 day moving average price is $18.06 and its two-hundred day moving average price is $20.33.

Insider Buying and Selling

In other news, insider Karen Mote sold 6,216 shares of the company’s stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $16.95, for a total value of $105,361.20. Following the sale, the insider now directly owns 35,101 shares in the company, valued at approximately $594,961.95. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 4.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CCRN. Truist Financial lowered their price objective on shares of Cross Country Healthcare from $22.00 to $16.00 and set a “hold” rating on the stock in a research note on Thursday, February 22nd. Barrington Research decreased their price target on shares of Cross Country Healthcare from $26.00 to $24.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 27th. TheStreet lowered shares of Cross Country Healthcare from a “b-” rating to a “c+” rating in a research report on Friday, March 1st. Finally, Benchmark lowered their price target on Cross Country Healthcare from $24.00 to $21.00 and set a “buy” rating on the stock in a research note on Thursday, February 22nd. Six investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $21.67.

About Cross Country Healthcare

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.